Position in BIIB
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$377,240
+$96,929 QoQ
Shares Held
1,746
+14.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#622
of 1,031 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RIVERSEDGE ADVISORS, LLC holds $8,081,117 across 10 Drug Manufacturers - General names. BIIB ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,231 | $1,582,487 | |
| 2 | LLY |
ELI LILLY & Co
|
1,159 | $1,390,139 | |
| 3 | ABBV |
AbbVie Inc.
|
4,666 | $1,174,152 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,575 | $1,127,911 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,880 | $884,080 | |
| 6 | NVS |
Novartis AG
|
3,883 | $608,543 | |
| 7 | AZN |
Astrazeneca PLC
|
2,280 | $432,333 | |
| 8 | BIIB |
Biogen Inc.
This page
|
1,746 | $377,240 |
All Filings in BIIB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,240 | 1,746 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $280,311 | 1,529 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $226,675 | 1,288 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||